Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer
Clinical trial NCT01253369 · COMPLETED
Trial details
- NCT number
- NCT01253369
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-09-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.